Paroxysmal Nocturnal Hemoglobinuria Presenting With Progressive Biventricular Thrombi
Case Reports in Hematology · 2026-01 · 2026 (1)
DOI: 10.1155/crh/5349577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Hematology, online erschienen am 03.06.2026. Verfasst von Jordan S Nunnelee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A 34‐year‐old previously healthy woman presented with right‐sided, pleuritic chest pain three weeks after a viral respiratory infection. Labs revealed hemoglobin of 10.2 g/dL (nadir 7.0), platelets of 109 × 10 9 /L, LDH of 1129 U/L (Ref: 122‐222 U/L), undetectable haptoglobin, indirect hyperbilirubinemia, and elevated reticulocytes. Troponins were elevated. CRP was 184 mg/L (Ref: ≤ 5 mg/L). Peripheral smear was without schistocytes. Direct antiglobulin testing was negative. Urinalysis showed microscopic hematuria and positive hemosiderin. Echocardiogram revealed normal left ventricular (LV) function with left lateral wall hypokinesis and a 2.5 × 3 cm LV thrombus. Cardiac MRI was concerning for myopericarditis and new right ventricular (RV) thrombus, later verified by biopsy. There was also an infarction of the RV endomyocardium. Anticoagulation was initiated. Bone marrow biopsy showed erythroid hyperplasia without clonal myeloid features. Flow cytometry showed 57% CD59 deficient red blood cells, 88% CD157 deficient monocytes, and 91% CD157 deficient neutrophils, consistent with a new diagnosis of paroxysmal nocturnal hemoglobinuria (PNH). She was urgently vaccinated against encapsulated organisms, treated with eculizumab, and given antibacterial prophylaxis. Follow‐up imaging showed near resolution of thrombi; hemoglobin and hemolysis markers normalized. PNH is a clonal hematopoietic disorder causing complement‐mediated hemolysis and thrombosis. While thrombosis typically affects atypical venous sites, intracardiac thrombi are rare. PNH was the patient’s only identified prothrombotic factor. This is the first reported case of intracardiac thrombosis in a previously healthy patient with new‐onset PNH. Early recognition and complement inhibition are critical to reduce hemolysis, thrombosis, and mortality in PNH.
Autor:innen und Institutionen
- Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Department of Hematology and Oncology, Gundersen Medical Foundation, La Crosse, Wisconsin, USA, gundersenhealth.org.
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Division of Cardiovascular Anesthesia, Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
ORCID-Profile: Jordan S Nunnelee, Nicholas P Bergeron, Andrew J Layman, David Dingli, Richard C Godby
Zitieren
APA
Nunnelee, J. S., Weber, G. A., Bergeron, N. P., Talbott, K. E., Layman, A. J., Dingli, D., & Godby, R. C. (2026). Paroxysmal Nocturnal Hemoglobinuria Presenting With Progressive Biventricular Thrombi. Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/5349577
Vancouver
Nunnelee JS, Weber GA, Bergeron NP, Talbott KE, Layman AJ, Dingli D, et al. Paroxysmal Nocturnal Hemoglobinuria Presenting With Progressive Biventricular Thrombi. Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/5349577
BibTeX
@article{Nunnelee2026,
author = {Nunnelee, Jordan S and Weber, Garrett A and Bergeron, Nicholas P and Talbott, Katherine E and Layman, Andrew J and Dingli, David and Godby, Richard C},
title = {Paroxysmal Nocturnal Hemoglobinuria Presenting With Progressive Biventricular Thrombi},
journal = {Case Reports in Hematology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crh/5349577}
}
EUVIMED